EXPERT OPINION ON INVESTIGATIONAL DRUGS
EXPERT OPINION ON INVESTIGATIONAL DRUGS
期刊ISSN: 1354-3784
E-ISSN: 1744-7658
影响因子: 登录后查看数据
自引率: 2.4%
SCI期刊JCR分区
SCI期刊JCR分区等级:1区
按学科分区
PHARMACOLOGY & PHARMACY
Q1
PHARMACOLOGY & PHARMACY
Q2
《新锐期刊分区表》(2026年3月发布)
大类学科
医学
3区
小类学科
药学
3区
Top期刊
综述期刊
最新中科院SCI期刊分区(2025年3月升级版)
大类学科
医学
3区
小类学科
药学
2区
Top期刊
综述期刊
期刊简介
Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development. The Editors welcome: Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies Drug Evaluations reviewing the clinical and pharmacological data on a particular drug Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.
出版信息
出版商
Taylor and Francis Ltd.
涉及的研究方向
医学-药学
刊期
Monthly
年文章数
99
出版国家或地区
ENGLAND
是否OA
Cite Score(2025年最新版)
Cite Score SJR SNIP 排名
8.3 1.267 0.898
学科
大类学科:Medicine
小类学科:Pharmacology (medical)
分区
Q1
学科
大类学科:Medicine
小类学科:Pharmacology
分区
Q1
SCI期刊投稿推荐
中科院分区相关期刊
去登录